Mafalda Oliveira

发表论文 228 篇 · 总被引 9470 次 · h-index 41

代表论文

• Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression (2024 · Journal of Clinical Oncology · 被引 144)
• Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Early Breast Cancer: A Systematic Review and Meta-Analysis. (2024 · JAMA Oncology · 被引 80)
• Capivasertib and fulvestrant for patients with hormone receptor-positive, HER2-negative advanced breast cancer (CAPItello-291): patient-reported outcomes from a phase 3, randomised, double-blind, placebo-controlled trial. (2024 · The Lancet Oncology · 被引 33)
• TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancer (2025 · Therapeutic Advances in Medical Oncology · 被引 26)
• Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response (2024 · Nature Communications · 被引 25)
• Landscape of neoadjuvant therapy in HER2-positive breast cancer: a systematic review and network meta-analysis. (2023 · European Journal of Cancer · 被引 24)